Innate immunity in Alzheimer's disease (Q38358574)

2 September 2017

1 reference

title

Innate immunity in Alzheimer's disease (English)

1 reference

2 September 2017

0 references

2

Douglas T Golenbock

1 reference

2 September 2017

Michael T Heneka

1

1 reference

2 September 2017

Eicke Latz

series ordinal

3

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 March 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

16

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

229-236

1 reference

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

2 September 2017

cites work

1 reference

21 January 2018

1 reference

The genetics of Alzheimer disease: back to the future

21 January 2018

1 reference

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

The curli nucleator protein, CsgB, contains an amyloidogenic domain that directs CsgA polymerization

21 January 2018

1 reference

Role of Escherichia coli curli operons in directing amyloid fiber formation

21 January 2018

1 reference

Polymerizing the fibre between bacteria and host cells: the biogenesis of functional amyloid fibres.

21 January 2018

1 reference

Inflammatory Blockade Restores Adult Hippocampal Neurogenesis

21 January 2018

1 reference

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

21 January 2018

1 reference

In-vivo measurement of activated microglia in dementia

21 January 2018

1 reference

Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106.

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

21 January 2018

1 reference

Alzheimer's disease genetics: from the bench to the clinic

21 January 2018

1 reference

TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation

21 January 2018

1 reference

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

21 January 2018

1 reference

MyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's disease

21 January 2018

1 reference

The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL/6 and APPswe/PS1dE9 mice

21 January 2018

1 reference

CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

21 January 2018

1 reference

Amyloid-β Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity

21 January 2018

1 reference

Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.

21 January 2018

1 reference

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

21 January 2018

1 reference

In Vivo Human Amyloid Imaging

21 January 2018

1 reference

ATP mediates rapid microglial response to local brain injury in vivo

21 January 2018

1 reference

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

21 January 2018

1 reference

Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study

21 January 2018

1 reference

Activation and regulation of the inflammasomes

21 January 2018

1 reference

The NALP3 inflammasome is involved in the innate immune response to amyloid-beta

21 January 2018

1 reference

Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1β via p38 mitogen-activated protein kinase

21 January 2018

1 reference

Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging

21 January 2018

1 reference

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

21 January 2018

1 reference

Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.

21 January 2018

1 reference

Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis.

21 January 2018

1 reference

Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease

21 January 2018

1 reference

Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice.

21 January 2018

1 reference

Synaptic pruning by microglia is necessary for normal brain development

21 January 2018

1 reference

Immune modulation of learning, memory, neural plasticity and neurogenesis

21 January 2018

1 reference

Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system

21 January 2018

1 reference

Interleukin-18 mediated inhibition of LTP in the rat dentate gyrus is attenuated in the presence of mGluR antagonists.

21 January 2018

1 reference

Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide.

21 January 2018

1 reference

Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathology

21 January 2018

1 reference

Acidic Fibroblast Growth Factor (FGF) Potentiates Glial-mediated Neurotoxicity by Activating FGFR2 IIIb Protein

21 January 2018

1 reference

CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.

21 January 2018

1 reference

Neuronal death induced by nanomolar amyloid β is mediated by primary phagocytosis of neurons by microglia

21 January 2018

1 reference

Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.

21 January 2018

1 reference

The role of microglia in amyloid clearance from the AD brain

21 January 2018

1 reference

Regulation of Tau Pathology by the Microglial Fractalkine Receptor

21 January 2018

1 reference

Inflammation induced by infection potentiates tau pathological features in transgenic mice

21 January 2018

1 reference

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

21 January 2018

1 reference

Accumulation of tau induced in neurites by microglial proinflammatory mediators

21 January 2018

1 reference

Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model

21 January 2018

1 reference

Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

21 January 2018

1 reference

Mrp14 deficiency ameliorates amyloid β burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing

21 January 2018

1 reference

Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases.

21 January 2018

1 reference

CD45 Deficiency Drives Amyloid-β Peptide Oligomers and Neuronal Loss in Alzheimer's Disease Mice

21 January 2018

1 reference

Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia

21 January 2018

1 reference

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

21 January 2018

1 reference

Identification of a CD20-, FcepsilonRIbeta-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse

21 January 2018

1 reference

Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling

21 January 2018

1 reference

CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

21 January 2018

1 reference

Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta

21 January 2018

1 reference

Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease

21 January 2018

1 reference

TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice

21 January 2018

1 reference

Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.

21 January 2018

1 reference

A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells

21 January 2018

1 reference

Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors

21 January 2018

1 reference

Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease

21 January 2018

1 reference

PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.

21 January 2018

1 reference

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

21 January 2018

1 reference

Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death

21 January 2018

1 reference

Statins Promote the Degradation of Extracellular Amyloid β-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion

21 January 2018

1 reference

Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes

21 January 2018

1 reference

Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice

21 January 2018

1 reference

NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits

21 January 2018

1 reference

Microglia activation in sepsis: a case-control study

21 January 2018

1 reference

Systemic inflammation and disease progression in Alzheimer disease

21 January 2018

1 reference

Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis

21 January 2018

1 reference

Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors

21 January 2018

1 reference

TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects

21 January 2018

1 reference

Inflammation and Alzheimer's disease: possible role of periodontal diseases

21 January 2018

1 reference

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

Association of microglia with amyloid plaques in brains of APP23 transgenic mice

21 January 2018

1 reference

Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease

21 January 2018

1 reference

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25689443

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25689443

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25689443

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NI.3102

1 reference

Dimensions Publication ID

2 September 2017

1036887716

0 references

1 reference